EP0394265B1
(en)
|
1987-07-29 |
1994-11-02 |
The Liposome Company, Inc. |
Method for size separation of particles
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
KR0131678B1
(ko)
|
1991-12-09 |
1998-04-17 |
유미꾸라 레이이찌 |
파라티로이드 호르몬류의 안정화 조성물
|
US5302401A
(en)
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
JPH10511957A
(ja)
|
1995-01-05 |
1998-11-17 |
ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ ミシガン |
表面改質ナノ微粒子並びにその製造及び使用方法
|
JP4979843B2
(ja)
|
1995-03-10 |
2012-07-18 |
ロッシュ ディアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
微粒子の形のポリペプチド含有投薬形
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
US8038994B2
(en)
|
1996-05-15 |
2011-10-18 |
Quest Pharmatech Inc. |
Combination therapy for treating disease
|
JP2942508B2
(ja)
|
1997-01-14 |
1999-08-30 |
順也 藤森 |
温度感受性徐放性基剤及び温度感受性徐放性システム
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
JP2002519333A
(ja)
|
1998-06-30 |
2002-07-02 |
アムジエン・インコーポレーテツド |
生物学的に活性な物質の徐放運搬のための感熱性生分解性ヒドロゲル
|
US6265609B1
(en)
|
1998-07-06 |
2001-07-24 |
Guilford Pharmaceuticals Inc. |
Thio-substituted pentanedioic acid derivatives
|
US6395718B1
(en)
|
1998-07-06 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
|
KR100274842B1
(ko)
|
1998-10-01 |
2001-03-02 |
김효근 |
미립구를 이용한 레티노익산의 서방형 약물방출 시스템
|
DE19856432A1
(de)
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
FI982733A
(fi)
*
|
1998-12-17 |
2000-06-18 |
Orion Yhtymae Oyj |
Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
|
US7311924B2
(en)
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
AU6132700A
(en)
|
1999-09-30 |
2001-04-05 |
Chienna B.V. |
Polymers loaded with bioactive agents
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
US20050037086A1
(en)
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
KR100416242B1
(ko)
|
1999-12-22 |
2004-01-31 |
주식회사 삼양사 |
약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
|
US6890946B2
(en)
|
1999-12-23 |
2005-05-10 |
Indiana University Research And Technology Corporation |
Use of parthenolide to inhibit cancer
|
US7217770B2
(en)
|
2000-05-17 |
2007-05-15 |
Samyang Corporation |
Stable polymeric micelle-type drug composition and method for the preparation thereof
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
KR100418916B1
(ko)
|
2000-11-28 |
2004-02-14 |
한국과학기술원 |
생분해성 고분자와 항암제의 접합체를 이용한 서방형미셀제제의 제조방법
|
KR100446101B1
(ko)
|
2000-12-07 |
2004-08-30 |
주식회사 삼양사 |
수난용성 약물의 서방성 제형 조성물
|
DE60128261T3
(de)
|
2000-12-21 |
2016-06-30 |
Alrise Biosystems Gmbh |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
SI1345597T1
(sl)
|
2000-12-27 |
2007-12-31 |
Ares Trading Sa |
Amfifilni lipidni nanodelci za vgradnjo peptidov in/ali proteinov
|
DE60214134T2
(de)
|
2001-02-07 |
2007-07-19 |
Beth Israel Deaconess Medical Center, Boston |
Modifizierte psma-liganden und deren verwendung
|
WO2002080846A2
(en)
|
2001-04-03 |
2002-10-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
WO2003000014A2
(en)
|
2001-06-21 |
2003-01-03 |
Altus Biologics, Inc. |
Spherical protein particles and methods of making and using them
|
US7498045B2
(en)
|
2001-08-31 |
2009-03-03 |
Thomas M. S. Chang |
Biodegradable polymeric nanocapsules and uses thereof
|
US6592899B2
(en)
|
2001-10-03 |
2003-07-15 |
Macromed Incorporated |
PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
|
ES2541908T3
(es)
|
2001-10-10 |
2015-07-28 |
Pierre Fabre Medicament |
Microesferas biodegradables de liberación prolongada y su procedimiento de preparación
|
CN1592607A
(zh)
|
2001-10-15 |
2005-03-09 |
克里蒂泰克公司 |
水溶性差药物的组合物、其给药方法和治疗方法
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
IL162183A0
(en)
|
2001-12-21 |
2005-11-20 |
Celator Technologies Inc |
Polymer-lipid delivery vehicles and methods for the preparation thereof
|
EP1472541B1
(en)
|
2002-01-10 |
2009-09-16 |
The Johns Hopkins University |
Imaging agents and methods of imaging naaladase of psma
|
WO2003086369A2
(en)
|
2002-04-05 |
2003-10-23 |
Valorisation-Recherche, Societe En Commandite |
Stealthy polymeric biodegradable nanospheres and uses thereof
|
US20030232887A1
(en)
|
2002-04-10 |
2003-12-18 |
Johnson Douglas Giles |
Preparation and use of a stable formulation of allosteric effector compounds
|
US6890950B2
(en)
|
2002-04-23 |
2005-05-10 |
Case Western Reserve University |
Lapachone delivery systems, compositions and uses related thereto
|
JP2003342168A
(ja)
|
2002-05-24 |
2003-12-03 |
Nano Career Kk |
注射用薬物含有ポリマーミセル製剤の製造方法
|
WO2003103549A1
(en)
|
2002-06-05 |
2003-12-18 |
University Of Florida |
Ophthalmic drug delivery system
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
JP4530626B2
(ja)
*
|
2002-06-25 |
2010-08-25 |
武田薬品工業株式会社 |
徐放性組成物の製造方法
|
US7879351B2
(en)
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
CA2504268A1
(en)
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
CA2508279A1
(en)
|
2002-12-23 |
2004-07-22 |
Vical Incorporated |
Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes
|
US6841547B2
(en)
|
2003-02-28 |
2005-01-11 |
Albert Einstein College Of Medicine Of Yeshevia University |
Method for decreasing low density lipoprotein
|
US20040185170A1
(en)
|
2003-03-21 |
2004-09-23 |
Shubha Chungi |
Method for coating drug-containing particles and formulations and dosage units formed therefrom
|
EP1974726B1
(en)
|
2003-03-26 |
2010-01-13 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
JP2006521367A
(ja)
|
2003-03-26 |
2006-09-21 |
株式会社Lttバイオファーマ |
ターゲッティングと徐放を目的とした静脈注射用ナノ粒子
|
WO2004089291A2
(en)
|
2003-04-03 |
2004-10-21 |
Au Jessie L-S |
Tumor-targeting drug-loaded particles
|
US20040247624A1
(en)
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
US20050256071A1
(en)
|
2003-07-15 |
2005-11-17 |
California Institute Of Technology |
Inhibitor nucleic acids
|
US20050142205A1
(en)
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
CA2533314C
(en)
*
|
2003-07-18 |
2013-07-09 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
CA2533592C
(en)
|
2003-07-23 |
2015-11-10 |
Pr Pharmaceuticals, Inc. |
Controlled release compositions
|
WO2005020989A1
(en)
|
2003-09-02 |
2005-03-10 |
Novartis Ag |
Cancer treatment with epothilones
|
US7311901B2
(en)
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
US7846412B2
(en)
|
2003-12-22 |
2010-12-07 |
Emory University |
Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
|
WO2005084710A2
(en)
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
US20070053845A1
(en)
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
US8043631B2
(en)
|
2004-04-02 |
2011-10-25 |
Au Jessie L S |
Tumor targeting drug-loaded particles
|
US20080124400A1
(en)
|
2004-06-24 |
2008-05-29 |
Angiotech International Ag |
Microparticles With High Loadings Of A Bioactive Agent
|
EP1768692B8
(en)
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
JP2006131577A
(ja)
|
2004-11-09 |
2006-05-25 |
Ltt Bio-Pharma Co Ltd |
異なる粒子径を有する薬物封入ナノ粒子の作製方法および当該方法で得られたナノ粒子
|
EA011594B1
(ru)
|
2004-12-30 |
2009-04-28 |
Синвеншен Аг |
Композиция, включающая агент, обеспечивающий сигнал, имплантируемый материал и лекарство
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
CN101189016B
(zh)
|
2005-04-04 |
2013-03-27 |
因特尔赛克特耳鼻喉公司 |
治疗鼻窦病症的装置
|
JP2006321763A
(ja)
|
2005-05-20 |
2006-11-30 |
Hosokawa Funtai Gijutsu Kenkyusho:Kk |
生体適合性ナノ粒子及びその製造方法
|
AU2006282042B2
(en)
|
2005-06-17 |
2011-12-22 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials
|
KR20080031379A
(ko)
|
2005-07-11 |
2008-04-08 |
와이어쓰 |
글루타메이트 아그레카나제 저해제
|
CA2615122A1
(en)
|
2005-08-03 |
2007-02-15 |
Immunogen, Inc. |
Immunoconjugate formulations
|
AU2006284657B2
(en)
|
2005-08-31 |
2012-07-19 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
JP2009507049A
(ja)
|
2005-09-09 |
2009-02-19 |
北京徳科瑞医薬科技有限公司 |
リン脂質のポリエチレングリコール誘導体に包み込まれたビンカアルカロイド系制癌剤のナノミセル製剤
|
US20090022806A1
(en)
*
|
2006-12-22 |
2009-01-22 |
Mousa Shaker A |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
|
US20080267876A1
(en)
|
2005-09-20 |
2008-10-30 |
Yissum Research Development Company |
Nanoparticles for Targeted Delivery of Active Agent
|
US8916206B2
(en)
|
2005-12-26 |
2014-12-23 |
Ltt Bio-Pharma Co., Ltd. |
Nanoparticles containing water-soluble non-peptide low-molecular weight drug
|
US7842312B2
(en)
|
2005-12-29 |
2010-11-30 |
Cordis Corporation |
Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
|
US20090155349A1
(en)
|
2006-02-23 |
2009-06-18 |
Jonathan Daniel Heller |
Methods of treating influenza viral infections
|
DE102006013531A1
(de)
|
2006-03-24 |
2007-09-27 |
Lts Lohmann Therapie-Systeme Ag |
Polylactid-Nanopartikel
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
US8232245B2
(en)
|
2006-07-26 |
2012-07-31 |
Sandoz Ag |
Caspofungin formulations
|
EP2056793A4
(en)
|
2006-07-31 |
2011-08-17 |
Neurosystec Corp |
NANOPARTICLES WITH FREE BASE OF GACYCLIDINE
|
US20090247552A1
(en)
|
2006-07-31 |
2009-10-01 |
Shirou Sawa |
Aqueous liquid preparation containing amide compound
|
WO2008019142A2
(en)
|
2006-08-04 |
2008-02-14 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
US20080057102A1
(en)
|
2006-08-21 |
2008-03-06 |
Wouter Roorda |
Methods of manufacturing medical devices for controlled drug release
|
KR100946275B1
(ko)
|
2006-09-26 |
2010-03-08 |
주식회사 삼양사 |
수 난용성 캄토테신 유도체의 미세 나노입자 및 그의제조방법
|
EP2097111B1
(en)
|
2006-11-08 |
2015-07-15 |
Molecular Insight Pharmaceuticals, Inc. |
Heterodimers of glutamic acid
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
CN1957911A
(zh)
|
2006-12-01 |
2007-05-09 |
济南康泉医药科技有限公司 |
一种抗实体肿瘤缓释剂
|
CN1961864A
(zh)
|
2006-12-12 |
2007-05-16 |
济南帅华医药科技有限公司 |
一种抗癌的组合物
|
CN101396340A
(zh)
|
2006-12-12 |
2009-04-01 |
济南帅华医药科技有限公司 |
一种含埃坡霉素衍生物的抗癌缓释注射剂
|
CN1969818A
(zh)
|
2006-12-12 |
2007-05-30 |
济南帅华医药科技有限公司 |
一种含埃坡霉素衍生物的抗癌缓释注射剂
|
CN101433520A
(zh)
|
2006-12-12 |
2009-05-20 |
济南帅华医药科技有限公司 |
含埃坡霉素的抗癌缓释剂
|
CN1969816A
(zh)
|
2006-12-12 |
2007-05-30 |
济南帅华医药科技有限公司 |
一种含埃坡霉素的抗癌缓释剂
|
CN101396342A
(zh)
|
2006-12-12 |
2009-04-01 |
济南帅华医药科技有限公司 |
含埃坡霉素衍生物的抗癌缓释注射剂
|
WO2008091465A2
(en)
|
2006-12-21 |
2008-07-31 |
Wayne State University |
Peg and targeting ligands on nanoparticle surface
|
DK2481409T3
(en)
|
2007-03-07 |
2018-08-06 |
Abraxis Bioscience Llc |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
CN101053553B
(zh)
|
2007-03-16 |
2011-04-20 |
吉林大学 |
一种生物可降解氟尿嘧啶聚酯载药纳米球及其制备方法
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
EP2156848A4
(en)
|
2007-05-14 |
2012-11-28 |
Ltt Bio Pharma Co Ltd |
NANOPARTICLE CONTAINING A LOW MOLECULAR WEIGHT DRUG HAVING A NEGATIVELY PROLONGED RELEASE GROUP
|
WO2008151245A1
(en)
|
2007-06-04 |
2008-12-11 |
Sun Chemical Corporation |
Dispersions for plastic films
|
US8486423B2
(en)
|
2007-08-21 |
2013-07-16 |
Board Of Regents, The University Of Texas System |
Thermo-kinetic mixing for pharmaceutical applications
|
US20090061009A1
(en)
|
2007-08-29 |
2009-03-05 |
Joseph Schwarz |
Composition and Method of Treatment of Bacterial Infections
|
EP2436376B1
(en)
|
2007-09-28 |
2014-07-09 |
BIND Therapeutics, Inc. |
Cancer cell targeting using nanoparticles
|
US20090306120A1
(en)
|
2007-10-23 |
2009-12-10 |
Florencia Lim |
Terpolymers containing lactide and glycolide
|
US8974814B2
(en)
|
2007-11-12 |
2015-03-10 |
California Institute Of Technology |
Layered drug delivery polymer monofilament fibers
|
WO2009070302A1
(en)
|
2007-11-30 |
2009-06-04 |
The Johns Hopkins University |
Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
|
DE102007059752A1
(de)
|
2007-12-10 |
2009-06-18 |
Bayer Schering Pharma Aktiengesellschaft |
Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone
|
WO2009084801A1
(en)
|
2007-12-31 |
2009-07-09 |
Samyang Corporation |
Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same
|
EP2106806A1
(en)
|
2008-03-31 |
2009-10-07 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Nanoparticles for targeted delivery of active agents to the lung
|
US20090312402A1
(en)
|
2008-05-20 |
2009-12-17 |
Contag Christopher H |
Encapsulated nanoparticles for drug delivery
|
CN102099016A
(zh)
*
|
2008-06-16 |
2011-06-15 |
佰恩德生物科学股份有限公司 |
载药的聚合物纳米微粒及其制备和使用方法
|
ES2721850T3
(es)
|
2008-06-16 |
2019-08-05 |
Pfizer |
Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas
|
EP2309990B2
(en)
|
2008-06-16 |
2017-03-15 |
Pfizer Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
JP2011525180A
(ja)
|
2008-06-16 |
2011-09-15 |
バインド バイオサイエンシズ インコーポレイテッド |
治療的標的化ナノ粒子の製作に用いるためのジブロックコポリマーで官能化された標的薬の製造方法
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
RU2559525C2
(ru)
|
2008-07-08 |
2015-08-10 |
Эббви Инк |
Белки, связывающие простагландин е2, и их применение
|
WO2010030763A2
(en)
|
2008-09-10 |
2010-03-18 |
Bind Biosciences, Inc. |
High throughput fabrication of nanoparticles
|
US20110125090A1
(en)
|
2008-11-13 |
2011-05-26 |
Peyman Gholam A |
Ophthalmic drug delivery system and method
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
JP2012512175A
(ja)
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
WO2010114768A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
WO2010114770A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010117668A1
(en)
|
2009-03-30 |
2010-10-14 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
US7772274B1
(en)
*
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
ES2780156T3
(es)
|
2009-12-15 |
2020-08-24 |
Pfizer |
Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
|
EA201290498A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
|
WO2011084518A2
(en)
|
2009-12-15 |
2011-07-14 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
|
CN102740895B
(zh)
|
2009-12-23 |
2016-02-24 |
伊利诺伊大学董事会 |
纳米轭合物以及纳米轭合物配制品
|
US20110237686A1
(en)
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc |
Formulations and methods of use
|
WO2012040513A1
(en)
|
2010-09-22 |
2012-03-29 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for the delivery of beta lapachone
|
WO2012054923A2
(en)
|
2010-10-22 |
2012-04-26 |
Bind Biosciences, Inc. |
Therapeutic nanoparticles with high molecular weight copolymers
|
US20140308363A1
(en)
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
JP2014531456A
(ja)
|
2011-09-22 |
2014-11-27 |
バインド セラピューティックス インコーポレイテッド |
治療用ナノ粒子と癌を治療する方法
|
DK3181128T3
(da)
|
2012-01-13 |
2023-06-06 |
Xspray Pharma Ab Publ |
Farmaceutisk nilotinib-sammensætning
|
JP6229666B2
(ja)
*
|
2012-02-29 |
2017-11-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
活性化合物を取り込んだナノ粒子の製造プロセス
|
MX363147B
(es)
|
2012-09-17 |
2019-03-11 |
Pfizer Inc Star |
Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos para realizarlas y usarlas.
|
BR112015005940A2
(pt)
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
processo para a preparação de nanopartículas terapêuticas
|